Screener
Regeneron Pharmaceuticals REGN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's free cash flow?
- Regeneron Pharmaceuticals (REGN) reported free cash flow of $572.8M in Q2 2026.
- How has Regeneron Pharmaceuticals's free cash flow changed year-over-year?
- Regeneron Pharmaceuticals's free cash flow decreased by 38.1% year-over-year, from $925.4M to $572.8M.
- What is the long-term trend for Regeneron Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's free cash flow has grown at a -11.1% compound annual growth rate (CAGR), from $6.53B to $4.08B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Regeneron Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude